Literature DB >> 17296585

MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes.

Kikkeri N Naresh.   

Abstract

We investigated the expression of MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4) in 46 cases of follicular lymphoma (FL) and correlated this with grade and expression of CD10, Bcl-6 and Ki-67. The analysis suggests that MUM1 expression dichotomises FL into low-grade FL of CD10+/Bcl-6+/MUM1-/Ki-67low phenotype, and high-grade FL of CD10+/- /Bcl-6+/weak/MUM1+/ Ki-67high phenotype.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17296585     DOI： 10.3324/haematol.10682

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  11 in total

Review 1.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

2.  MUM-1 immunohistochemistry has high accuracy and reliability in the diagnosis of chronic endometritis: a multi-centre comparative study with CD-138 immunostaining.

Authors:  Ettore Cicinelli; Sergio Haimovich; Dominique De Ziegler; Nili Raz; Dana Ben-Tzur; Alessandra Andrisani; Guido Ambrosini; Nico Picardi; Viviana Cataldo; Marco Balzani; Rossana Cicinelli; Marco Noventa; Loris Marin; Pantaleo Greco; Leonardo Resta; Carlo Saccardi; Giovanni Buzzaccarini; Amerigo Vitagliano
Journal:  J Assist Reprod Genet       Date:  2021-11-17       Impact factor: 3.412

3.  Germinal Centre-Related Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Report of a Remission Case.

Authors:  Fang Liu; Fei Qi; Xiuying Zhang; Mei Cao; Shiguang Peng
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-06

4.  Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma.

Authors:  Gabriela Gualco; Eduardo M Queiroga; Lawrence M Weiss; Claudete E N Klumb; William J Harrington; Carlos E Bacchi
Journal:  Hum Pathol       Date:  2009-01-13       Impact factor: 3.466

5.  Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study.

Authors:  J W Sweetenham; B Goldman; M L LeBlanc; J R Cook; R R Tubbs; O W Press; D G Maloney; R I Fisher; L M Rimsza; R M Braziel; E D Hsi
Journal:  Ann Oncol       Date:  2009-10-29       Impact factor: 32.976

6.  BCL6, MUM1, and CD10 expression in mantle cell lymphoma.

Authors:  Gabriela Gualco; Lawrence M Weiss; William J Harrington; Carlos E Bacchi
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-03

7.  Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.

Authors:  Ellen Leich; Itziar Salaverria; Silvia Bea; Andreas Zettl; George Wright; Victor Moreno; Randy D Gascoyne; Wing-Chung Chan; Rita M Braziel; Lisa M Rimsza; Dennis D Weisenburger; Jan Delabie; Elaine S Jaffe; Andrew Lister; Jude Fitzgibbon; Louis M Staudt; Elena M Hartmann; Hans-Konrad Mueller-Hermelink; Elias Campo; German Ott; Andreas Rosenwald
Journal:  Blood       Date:  2009-05-26       Impact factor: 22.113

8.  A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701.

Authors:  Barbara W Grant; Sin-Ho Jung; Jeffrey L Johnson; Lale Kostakoglu; Eric Hsi; John C Byrd; Jeffrey Jones; John P Leonard; S Eric Martin; Bruce D Cheson
Journal:  Cancer       Date:  2013-08-06       Impact factor: 6.860

9.  Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma.

Authors:  E Klyuchnikov; U Bacher; K Woo Ahn; J Carreras; N M Kröger; P N Hari; G H Ku; E Ayala; A I Chen; Y-B Chen; J B Cohen; C O Freytes; R P Gale; R T Kamble; M A Kharfan-Dabaja; H M Lazarus; R Martino; A Mussetti; B N Savani; H C Schouten; S Z Usmani; P H Wiernik; B Wirk; S M Smith; A Sureda; M Hamadani
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

10.  Interferon Regulatory Factor 4 Regulates the Development of Polymorphonuclear Myeloid-Derived Suppressor Cells Through the Transcription of c-Myc in Cancer.

Authors:  Quan Yang; Hongyan Xie; Xing Li; Yuanfa Feng; Shihao Xie; Jiale Qu; Anqi Xie; Yiqiang Zhu; Lu Zhou; Jinxue Yang; Xiaohao Hu; Haixia Wei; Huaina Qiu; Wenjuan Qin; Jun Huang
Journal:  Front Immunol       Date:  2021-02-23       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.